In the British medical devices industry, there were 4 M&A deals announced in Q4 2023, worth a total value of $364.3m, according to GlobalData’s Deals Database. The $350m acquisition of LumiraDx by F. Hoffmann-La Roche was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in 2023 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.
In value terms, M&A activity in the UK increased by 387% in Q4 2023 compared with the previous quarter’s total of $74.8m and fell by 88% as compared to Q4 2022. Related deal volume decreased by 43% in Q4 2023 versus the previous quarter and was 43% lower than in Q4 2022.
The top-ranked financial advisors supporting these M&A deals in the UK in Q4 2023 were Singer Capital Markets; Capricorn Energy; Cavendish Financial with 2, 1, 1 deals respectively.
The top-ranked legal advisorss supporting these M&A deals in the UK Q4 2023 were CMS Legal Services EEIG; Gibson, Dunn & Crutcher; Morgan, Lewis & Bockius with 2, 2, 2 deals respectively.
See Also:
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In 2023 – Thematic Intelligence, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.